Quipt Home Medical Corp

Quipt Home Medical Corp. engages in the provision of in-home monitoring and disease management services including end-to-end respiratory solutions. Its services include sleep apnea and pap treatment, home ventilation, equipment solutions, daily and ambulatory aides, power mobility, respiratory equipment rental, and oxygen therapy. The company was founded on March 5, 1993 and is headquartered in Wilder, KY.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Quipt Home Medical Corp. engages in the provision of in-home monitoring and disease management services including end-to-end respiratory solutions. Its services include sleep apnea and pap treatment, home ventilation, equipment solutions, daily and ambulatory aides, power mobility, respiratory equipment rental, and oxygen therapy. The company was founded on March 5, 1997 and is headquartered in Wilder, KY.

Posts Very Strong Adjusted EBITDA % of Revenue of 23.5% for Fiscal Q4 and 22.8% for Fiscal Year 2023 Posts Very Strong Adjusted EBITDA % of Revenue of 23.5% for Fiscal Q4 and 22.8% for Fiscal Year 2023

Quipt Home Medical Reports Record Fourth Quarter and Fiscal Year 2023 Financial Results Posting Revenue Growth of 59% and Adjusted EBITDA Growth of 73%

CINCINNATI, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT) (TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fourth quarter and full year 2023 financial results on Monday, December 18, 2023. Gregory Crawford, Chief Executive Officer, and Hardik Mehta, Chief Financial Officer, will host a conference call for the investment community on Tuesday, December 19, 2023, at 10:00 a.m. (ET).

Quipt Home Medical Corp. to Announce Fourth Quarter and Full Year 2023 Financial Results on December 18, 2023

Quipt Home Medical provides in-home monitoring and disease management services, focusing on respiratory solutions. The company has expanded its operations to 26 states and serves nearly 300,000 patients. The stock has sold off following a dilutive share issuance, but the current price presents a reasonable margin of safety, but I'm not bullish yet.

Quipt Home Medical: On Hold Pending Confirmatory Data Points

Rekor Systems Inc

Business News Network (BNN) a cable channel owned by Bloomberg in Canada has a daily program called Market Call.  One regular guest is a portfolio manager, Bruce Campbell from a firm called Stone Castle Investment Management Inc. Based in Kelowna, British Columbia.

3 High-Growth Small-Cap Picks

CINCINNATI, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ:QIPT; TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, is very pleased to announce that it has acquired a business with operations in Mississippi, Texas and Louisiana reporting unaudited annual revenues (12 months ending June 30, 2023) of approximately $9 million ‎with anticipated Adjusted EBITDA (defined below) of $2 million post integration.

Quipt Announces Multi-State Acquisition Adding Approximately $9 Million in Annualized Revenues, and Anticipated $2 Million in Adjusted EBITDA Post Integration

The pullback in Quipt Home Medical Corp. has created a buying opportunity in my view as the stock price sets higher lows and breaks key technical levels. The company's Q3 numbers showed strong growth, with revenues up 64% YoY on 58% growth in the customer base. Quipt's economic characteristics, including its asset-light model and acquisition strategy, support its growth potential and intrinsic value.

Quipt: Continued Display Of Economic Growth Levers, Reiterate Buy

Quipt Home Medical Corp (NASDAQ:QIPT ) Q3 2023 Results Conference Call August 15, 2023 10:00 AM ET Company Participants Greg Crawford - Chairman, President and CEO Hardik Mehta - Chief Financial Officer Conference Call Participants Doug Cooper - Beacon Securities Richard Close - Canaccord Genuity Michael Freeman - Raymond James Ty Collin - Eight Capital Operator Thank you for standing by. This is the conference operator.

Quipt Home Medical Corp (QIPT) Q3 2023 Earnings Call Transcript

Posts Strong Adjusted EBITDA Margin of 23% and Sequential Organic Growth of 4% Posts Strong Adjusted EBITDA Margin of 23% and Sequential Organic Growth of 4%

Quipt Home Medical Reports Strong Operational Performance With Record Third Quarter Fiscal 2023 Financial Results Posting Revenue Growth of 64% and Adjusted EBITDA Growth of 80%

CINCINNATI, July 24, 2023 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company”) (NASDAQ:QIPT; TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced that members of its management team will host a webcasted fireside chat and participate in 1x1 meetings at the 43rd Annual Canaccord Growth Conference on August 9th - 10th, 2023. The conference will be held in person at the InterContinental Boston.

Quipt Home Medical to Participate at the 43rd Annual Canaccord Growth Conference

CINCINNATI, June 20, 2023 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, is very pleased to announce that it has received final approval to list its common shares on the Toronto Stock Exchange (the “TSX”) and will commence trading on the TSX at market open on June 21, 2023 under the symbol “QIPT”. Concurrent with the commencement of trading on the TSX, the common shares will be delisted and will cease trading on the TSX Venture Exchange.

Quipt Home Medical Announces Up-listing to the Toronto Stock Exchange

Quipt started the year on fire following its largest acquisition in company history. QIPT dropped following a capital raise intended to give the company the flexibility to make continued acquisitions in the future. After largely recovering its momentum after the capital raise, QIPT reported outstanding earnings results, but the stock plummeted on the concurrent announcement of an ATM.

Time To Focus On Quipt's Results, Reiterate Buy

CINCINNATI, June 01, 2023 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company” or “Quipt”) (NASDAQ: QIPT; TSXV: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced it has terminated its previously announced “at-the-market” (“ATM”) equity program put in place pursuant to an equity distribution agreement dated May 15, 2023 by and among the Company, Canaccord Genuity and Beacon ‎Securities Limited. The Company has not made use of this ATM and, has elected to terminate the ATM as a result of market conditions and to limit ‎uncertainty and unfavorable dilution for its shareholders during this period of global ‎market uncertainty.‎

Quipt Home Medical Announces Termination of At-The-Market Equity Program

CINCINNATI, May 23, 2023 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, is very pleased to announce it is on a preliminary list dated May 19, 2023 issued by FTSE Russell to join the Russell 2000 ® and 3000 ® Indexes at the conclusion of the 2023 Russell indexes annual reconstitution, effective after the U.S. market opens on June 26, 2023. Updates are provided by the Russell Microcap Index on May 26, June 2, June 9, June 16 and June 23.

Quipt Home Medical on Preliminary List to Join Russell 2000® and 3000® Indexes

Quipt Home Medical Corp. (NASDAQ:QIPT ) Q2 2023 Earnings Conference Call May 16, 2023 10:00 AM ET Company Participants Greg Crawford - Chairman & Chief Executive Officer Hardik Mehta - Chief Financial Officer Conference Call Participants Doug Cooper - Beacon Securities Rahul Sarugaser - Raymond James Stefan Quenneville - Echelon Capital Markets Ty Collin - Eight Capital. Julian Hung - Stifel Operator Thank you for standing by.

Quipt Home Medical Corp. (QIPT) Q2 2023 Earnings Call Transcript

Posts Strong Adjusted EBITDA Margin of 22.5% and Sequential Organic Growth of 2.5% Posts Strong Adjusted EBITDA Margin of 22.5% and Sequential Organic Growth of 2.5%

Quipt Home Medical Reports Record Second Quarter Fiscal 2023 Financial Results Posting Revenue Growth of 73% and Adjusted EBITDA Growth of 86%

CINCINNATI, May 08, 2023 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT) (TSXV: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced that it will host its Fiscal Q2 2023 earnings conference call and audio webcast on Tuesday, May 16, 2023 at 10:00 a.m. (ET).

Quipt Home Medical Announces Date and Time for Fiscal Q2 2023 Conference Call and Audio Webcast

CINCINNATI, May 02, 2023 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, is very pleased to announce that it has received conditional approval from the Toronto Stock Exchange ("TSX") to graduate its listing from the TSX Venture Exchange (the "TSXV") to the TSX.

Quipt Home Medical Receives Conditional Approval to Graduate to the Toronto Stock Exchange

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CINCINNATI, April 25, 2023 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based home medical equipment provider focused on end-to-end respiratory care‎, is pleased to announce that it has closed its previously announced bought deal public offering (the “Public Offering”) of common shares in the capital of the Company (the “Common Shares”). The Public Offering was conducted through a syndicate of underwriters led by Beacon Securities Limited and Canaccord Genuity Corp. (the “Co-Lead Underwriters”) on behalf of a syndicate of underwriters including Echelon Wealth Partners Inc., Raymond James Ltd.

Quipt Home Medical Announces Closing of Public Offering and Private Placement for Aggregate Gross Proceeds of $42.5 Million

The specialty healthcare goods and services provider announced a new fundraising effort. It is garnering around $37 million with a pair of stock issues.

Why Quipt Home Medical Stock Got Rocked Today

Quipt Home Medical has caught a tremendous bid the last 6 months and is well poised to continue the rally. Its latest numbers are supportive to continue the growth route and drive attractive rates of cash to shareholders.

Quipt: Business Economics Attractive On Lower Capital Density

Opportunity to Accelerate Long-Term Organic Growth and Expand Patient Access Opportunity to Accelerate Long-Term Organic Growth and Expand Patient Access

Quipt Home Medical Announces New National Insurance Contract with Top 5 Health Insurer Based on Membership in the United States

Webcasted Presentation To Be Held Wednesday, March 22, 2023 Webcasted Presentation To Be Held Wednesday, March 22, 2023

Quipt Home Medical to Participate at the Sidoti Small-Cap Virtual Investor Conference on March 22-23, 2023

CINCINNATI, Ohio, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, is very pleased to announce it has been named to the 2023 TSX Venture 50® for the Clean Tech & Life Sciences industry. The Venture 50™ shines a light on the top-performing companies from Canada and around the world that are driving growth across their respective sectors. There are over 1,700 companies listed on the TSX Venture Exchange.

Quipt Home Medical Named as a Top Performing Company to the 2023 TSX Venture 50 List

Value Alpha is an individual investor with 12+ years of experience in strategy, M&A and investment decision making across multiple industries including services, healthcare and telecom. The importance of over-indexing on the quality of the people who are running the business, how to identify mispricings and best practices for doing a peer comp and relative valuation analysis.

SA Interview: Growth At A Reasonable Price Investing With Value Alpha

Quipt Home Medical Corp. (NASDAQ:QIPT ) Q1 2023 Earnings Conference Call February 14, 2023 10:00 AM ET Company Participants Greg Crawford – Chairman and Chief Executive Officer Hardik Mehta – Chief Financial Officer Conference Call Participants Doug Cooper – Beacon Securities Rahul Sarugaser – Raymond James Tania Armstrong-Whitworth – Canaccord Genuity Justin Keywood – Stifel Stefan Quenneville – Echelon Capital Markets Operator Thank you for standing by. This is the conference operator.

News for Quipt Home Medical Corp Stock (QIPT)